CLASS II Drug recall · Reported 1 Jan 2025 · FDA Enforcement Report
Kit for the Preparation of Technetium Tc 99m Sestamibi recalled
Curium US is recalling Kit for the Preparation of Technetium Tc 99m Sestamibi Injection, Each Kit contains: 30, distributed nationwide in the US. The recall was initiated on 26 Nov 2024 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0164-2025
- FDA event ID
- 95839
- Recalling firm
- Curium US, Maryland Heights, MO
- Manufacturer
- Curium US LLC
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 26 Nov 2024
- FDA classified
- 26 Dec 2024
- Reported
- 1 Jan 2025
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Sterility
- Drug class
- Injectable & IV Drugs
Timeline
| 26 Nov 2024 | Recall initiated by company | |
| 26 Dec 2024 | Classified by FDA | +30 days |
| 1 Jan 2025 | Published in enforcement report | +6 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Lack of Assurance of Sterility; Improper crimps on vials impacting the integrity of the product
A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.
Product as listed by the FDA
Kit for the Preparation of Technetium Tc 99m Sestamibi Injection, Each Kit contains: 30 sterile and non-pyrogenic reaction vials each containing Tetrakis (2-methoxy isobutyl isonitrile) Copper (I) tetratluoroborate - 1 mg; Stannous Chloride Dihydrate - 0.D75 mg; L-Cysteine Hydrochloride Monohydrate - 1 mg; Sodium Citrate Dihydrate - 2.6 mg; Mannitol - 20 mg. The pH is adjusted to 5.6 to 5.7 with HCI or NaOH prior to lyophilization. Sealed under nitrogen. 30 Radioassay Information Labels with radiation warning symbol. 1 package insert, Rx only, Manufacture by: Curium US LLC, Maryland Heights, MO 63043, 69945-092-40
Where it was distributed
Nationwide USA and Canada.
Questions about this recall
Why was it recalled?
Lack of Assurance of Sterility; Improper crimps on vials impacting the integrity of the product
Which lots are affected?
Lot 092-24006, Catalog # N092D0, Exp 06/15/2026
Where was it sold?
Nationwide USA and Canada.
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.